|
2025
|
Invention
|
3-[(1h-pyrazol-4-yl)oxy]pyrazin-2-amine compounds as hpk1 inhibitor and use thereof.
Disclosed h... |
|
|
Invention
|
Bcl-2 inhibitor.
Disclosed herein is a compound of Formula (I) for inhibiting both Bcl-2 wild ty... |
|
|
Invention
|
Heterocyclic compounds, compositions thereof, and methods of treatment therewith.
Provided herei... |
|
|
Invention
|
Anti-fgfr2b antibodies, conjugates and methods of use.
Anti-FGFR2b antibodies and antigen-bindin... |
|
|
Invention
|
Anti-fgfr2b antibodies, conjugates and methods of use. Anti-FGFR2b antibodies and antigen-binding... |
|
2024
|
Invention
|
Antibody drug conjugate platforms. The present disclosure provides antibody drug conjugate platfo... |
|
|
Invention
|
Degradation of irak4 by conjugation of irak4 inhibitors with e3 ligase ligand and methods of use.... |
|
|
Invention
|
Antibody drug conjugates.
Antibody-drug conjugate compounds comprising a linker and methods of u... |
|
|
Invention
|
Anti-cmet antibodies and methods of use.
The present disclosure provides for antibody or antigen... |
|
|
Invention
|
Anti-gpc3 and anti-cd137 multispecific antibodies and methods of use.
The present disclosure pro... |
|
|
Invention
|
Anti-ccr8 antibodies and methods of use.
The present disclosure provides antibodies and antigen-... |
|
|
Invention
|
Substituted 7-(pyrimidin-4-yl)quinolin-4(1h)-one compounds as cyclin dependent kinase inhibitors.... |
|
|
Invention
|
Polymorph forms of a 5h-pyrrolo[2,3-b]pyrazine derivative, methods of preparation, and uses there... |
|
|
Invention
|
Small molecule il-17a modulators.
Disclosed herein are fused bi-cyclic compounds used as Small M... |
|
|
Invention
|
Bcl-xl inhibitors.
Disclosed herein is a compound of Formula (I) for inhibiting Bcl-xL and treat... |
|
|
Invention
|
Anti-ox40 antibodies and methods of use.
The present disclosure provides antibodies and antigen-... |
|
|
Invention
|
Anti-dxd antibodies and methods of use.
The present disclosure provides antigen-binding fragment... |
|
|
Invention
|
Two-stage multi-task learning-based method and system for automated lesion response assessment. A... |
|
|
Invention
|
Degradation of (egfr) by conjugation of egfr inhibitors with e3 ligase ligand and methods of use.... |
|
|
Invention
|
Thiazolopyridyl amide derivatives as dna polymerase theta inhibitors.
The present invention rela... |
|
|
Invention
|
Bioactive conjugates, preparation method and use thereof. Compounds of formula (I) are provided, ... |
|
|
Invention
|
Bioactive conjugates, preparation method and use thereof. Compounds of formula (Ia) are provided,... |
|
|
Invention
|
Bcl-2 inhibitors.
Disclosed herein is a compound of Formula (I) for inhibiting Bcl-2 and treatin... |
|
|
Invention
|
Benzofuran derivatives as sik inhibitors and use thereof. Provided are compounds of formula (I) a... |
|
|
Invention
|
Compounds for the degradation of egfr kinase. Disclosed herein are novel bifunctional compounds f... |
|
|
Invention
|
Methods of cancer treatment using anti-ox40 antibodies in combination with anti-pd1 antibodies. P... |
|
|
Invention
|
Isoquinolinone derivatives and 4h-quinolizinone derivatives and pharmarceutical compositions ther... |
|
|
Invention
|
3-[(1h-pyrazol-r-yl)oxy]pyrazin-2-amine compounds as hpk1 inhibitor and use thereof. Disclosed he... |
|
|
Invention
|
Substituted 6-(pyrimidin-4-yl)quinoline compounds as cyclin dependent kinase inhibitors.
This di... |
|
|
Invention
|
Pyrazolopyridinone compounds.
Disclosed herein is a compound of Formula (I) for activating T cel... |
|
|
Invention
|
Methods of cancer treatment using a combination of btk inhibitors and pi3 kinase inhibitors.
Dis... |
|
|
Invention
|
Muc1 and cd16a antibodies and methods of use. The present disclosure provides for multi-specific ... |
|
|
Invention
|
Self-stabilizing linker conjugates. The present disclosure provides antibody drug conjugate platf... |
|
|
Invention
|
Condensed heterocyclic compounds as inhibitor of diacylglycerol kinases. Disclosed herein is a co... |
|
|
Invention
|
Heterocyclic compounds. Disclosed herein is a compound of Formula (I) which is a DGKs inhibitor, ... |
|
|
Invention
|
5-amino-1h-pyrrolo [3, 2-b] pyridine-2-carboxamide derivatives as mta-cooperative inhibitors of p... |
|
|
Invention
|
Anti-cmet antibodies and methods of use. The present disclosure provides for antibody or antigen-... |
|
2023
|
Invention
|
Anti-b7h3 antibodies and methods of use. The present disclosure provides for antibody or antigen-... |
|
|
Invention
|
B7h3 antibody drug conjugates. Antibody drug conjugates comprise an antibody or antigen binding f... |
|
|
Invention
|
Anti-cea antibody drug conjugates and methods of use. The present disclosure provides antibody dr... |
|
|
Invention
|
Anti-cd137 antibodies and methods of use. The present disclosure provides for the antibodies or a... |
|
|
P/S
|
Enseignement, à savoir mise à disposition d'un site web proposant de carnets web (blogs) et des p... |
|
|
P/S
|
Education, namely, providing a website offering blogs and
non-downloadable publications in the n... |
|
|
P/S
|
Educational services; providing online information about
education; arranging and conducting of ... |
|
2021
|
P/S
|
chemical preparations for pharmaceutical purposes; Crude drugs; chemico-pharmaceutical preparatio... |
|
|
P/S
|
Advertising; personnel management consultancy; accounting; business management assistance; sponso... |
|
|
P/S
|
Advertising agencies; personnel management consultancy; accounting; business management assistanc... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammato... |
|
|
P/S
|
Pharmaceutical preparations; chemico-pharmaceutical preparations; drugs for medical purposes; bio... |
|
|
Invention
|
Anti-nkp30 antibodies and methods of use.
Antibodies and antigen-binding fragments thereof that ... |
|
2020
|
P/S
|
Providing secure online web messaging and telecommunications services, namely, electronic transmi... |
|
|
P/S
|
Medicines for human purposes; cachets for pharmaceutical purposes; capsules for medicines; pharma... |
|
|
P/S
|
Medicines for human purposes, Cachets for pharmaceutical purposes, Capsules for medicines, pharma... |
|
2019
|
P/S
|
Pharmaceuticals; pharmaceutical preparations; chemico-pharmaceutical preparations; biological pre... |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer, Pharmaceuticals for the treatment of autoimmune dise... |
|
2018
|
P/S
|
Pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious ... |
|
|
P/S
|
Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparati... |
|
|
P/S
|
Medicines for human purposes, cachets for pharmaceutical purposes, capsules for medicines, pharma... |
